Skip to main content
Show — Main navigation Hide — Main navigation
  • Home
  • About
    • The Chair
    • Inquiry Team
    • Expert Groups
    • Inquiry Intermediaries
    • Core Participants
    • Legal Representatives
    • Inquiry Memorial
    • Financial Reports
  • Approach
    • Terms of reference
    • List of Issues
    • Statements of approach
    • Inquiry Principles
  • News
    • News
    • Newsletter Archive
  • Reports
    • The Inquiry Report
    • Additional Compensation Report
    • First Interim Report
    • Second Interim Report
    • Compensation Framework Study
  • Evidence
    • Evidence
    • Hearings Archive
  • Compensation
  • Support
    • Support and FAQs
    • NHS Psychological Support
    • Support Groups
    • Infected Blood Support Schemes
    • Hepatitis C Testing
  • Contact us
Accessibility Tool
  • Zoom in
  • Zoom out
  • Reset
  • Contrast
  • Accessibility tool
Get in touch

Quick Exit

Subscribe to Search results

Dr Jay Hoofnagle and others wrote that until the nature of NANBH was "elucidated", blood and blood products should be considered as potentially infectious.

Published on: 22 July, 2024

An article by Dr Jay Hoofnagle and others emphasised that NANBH could progress to chronic hepatitis and was linked to persistent liver damage.

Published on: 22 July, 2024

An article by Dr Harvey Alter emphasised that NANBH could progress to chronic hepatitis.

Published on: 22 July, 2024

The Lancet published a study by Dr Eric Preston and others showing chronic liver disease in patients with haemophilia treated with factor concentrates.

Published on: 22 July, 2024

Dr Peter Kernoff wrote to Dr Brian Colvin describing NANBH as "a serious disease with long-term consequences".

Published on: 22 July, 2024

Dr Diana Walford described NANBH as a form of hepatitis that could "be rapidly fatal" or "lead to progressive liver damage".

Published on: 22 July, 2024

A British Medical Journal editorial referred to post-transfusion hepatitis as "the major complication of the modern treatment of haemophilia".

Published on: 22 July, 2024

CDC reported a further 36 cases.

Published on: 22 July, 2024

CDC reported an additional 70 cases.

Published on: 22 July, 2024

Cases of failure of the immune system were reported in intravenous drug users.

Published on: 22 July, 2024

AIDS discussed at Second International Symposium on Infections in the Immunocompromised Host, Stirling, Scotland.

Published on: 22 July, 2024

The Observer reported "major speculation" that AIDS virus is "carried in the blood".

Published on: 22 July, 2024

AIDS discussed at the UK Haemophilia Centre Directors Hepatitis Working Party meeting.

Published on: 22 July, 2024

Meeting at Heathrow between haemophilia doctors and Immuno took place.

Published on: 22 July, 2024

The Lancet reported that bloodborne agent seemed likely cause of AIDS.

Published on: 22 July, 2024

The New Scientist suggested "prime suspect" was blood borne virus.

Published on: 22 July, 2024

ln his letter to Professor Arthur Bloom, Dr Bruce Evatt (CDC) said that the AIDS epidemic was evolving with a frightening pace.

Published on: 22 July, 2024

Professor Bloom reported probable case of AIDS to CDSC.

Published on: 22 July, 2024

Article in The Mail on Sunday described risk of AIDS.

Published on: 22 July, 2024

Professor Bloom's letter regarding AIDS published by the Haemophilia Society.

Published on: 22 July, 2024

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 1960
  • Page 1961
  • Page 1962
  • Page 1963
  • Current page 1964
  • Page 1965
  • Page 1966
  • Page 1967
  • Page 1968
  • …
  • Next page Next
  • Last page Last

Inquiry

  • Home
  • About
  • Approach
  • News
  • Evidence
  • Support
  • Get in touch

Legal

  • Terms & Conditions
  • Cookies notice
  • Privacy Notice
  • Accessibility tool

Address

Infected Blood Inquiry
5th Floor
Aldwych House
71-91 Aldwych
London
WC2B 4HN
 
Images of individuals on the website are used with the agreement of those featured or are stock images.

Follow us

© Crown copyright. Licensed under the Open Government Licence v3.0 except where otherwise stated.